Skip to content
Abierto
Menu

Combined synopsis and solicitation

Illumina NextSeq 2000 Sequencing System, or equal instrument, plus one option year of post warranty maintenance

75F40124Q123407

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

View on SAM.govMarkdown

Awarded

Illumina, Inc.

$233,747.00 obligated so far on USAspending

Description

As published on SAM.gov.

See attached Request for Quote (RFQ) for an Illumina NextSeq 2000 Sequencing System, or equal instrument, plus one option year of post warranty maintenance. Please pay close attention to FAR 52.212-1, Instructions to Offerors and FAR 52.212-2 Evaulation-Commercial Products and Commercial Services (pages 18-21 of the RFQ) so that you may provide the necessary information to be responsive to the solicitation.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Illumina, Inc.
UEI
KMW3CRWNAAF3
CAGE
1WCS2
Vendor location
San Diego, CA
Contract
75F40124P00219, purchase order
Obligated
$233,747.00
Actions
3 between June 17, 2024 and July 23, 2025
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Illumina Nextseq 2000 Sequencing System Plus One Option Year of Post Warranty Maintenance
Match
solicitation number 75F40124Q123407 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 29, 2024

    Combined synopsis and solicitation, originally sources sought

    Due June 6, 2024 at 10:00 AM EDT. SAM.gov, notice 078cbbaed73441099bfef20415f22655

Points of contact

Also open from this buyer